Direxion Nanotechnology ETF
TYNE
TYNE was delisted on the 17th of February, 2023.
6 hedge funds and large institutions have $1.48M invested in Direxion Nanotechnology ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
26% less capital invested
Capital invested by funds: $2.01M → $1.48M (-$527K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$122K |
TYNE Hedge Fund Activity: Q1 2022 in Review
6 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Direxion Nanotechnology ETF (TYNE) for Q1 2022, worth a combined $1.48M — down 26% from $2.01M a quarter earlier.
Fund positioning in TYNE was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was JP Morgan Chase, cutting an estimated $122K.
- 6 institutional investors held Direxion Nanotechnology ETF (TYNE) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $1.48M of Direxion Nanotechnology ETF stock for Q1 2022, down 26% quarter-over-quarter.
- 0 funds opened new Direxion Nanotechnology ETF positions in Q1 2022 and 0 closed out.
- The largest Direxion Nanotechnology ETF seller in Q1 2022 was JP Morgan Chase, an estimated $122K sold.
Based on aggregated 13F filings for Q1 2022.